A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automate...
A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Schizophrenia (SCZ) is a chronic, severe, and complex psychiatric disorder that affects all aspects of personal functioning. While SCZ has a very strong biological component, there are still no objective diagnostic tests. Lately, special attention has been given to epigenetic biomarkers in SCZ. In this study, we introduce a three-step, automated ma...
Alternative Titles
Full title
A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b5da2d1df7284b378942bed2b3f251c2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b5da2d1df7284b378942bed2b3f251c2
Other Identifiers
ISSN
2158-3188
E-ISSN
2158-3188
DOI
10.1038/s41398-024-02946-4
